WEGOVY ® (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity: to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.

WEGOVY ® (semaglutide) injection 2.4 mg is an injectable prescription medicine used with a reduced calorie diet and increased physical activity: to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight.

Jan 16, 2025 · Wegovy is a prescription medicine given as an injection once-a-week given under the skin. This medicine should be used together with a decreased-calorie meal plan and increased physical activity to help weight management.

Aug 1, 2024 · Learn about cost, uses, and more for Wegovy (semaglutide), a prescription injection for weight management and reduction of cardiovascular risks.

Wegovy ® comes in 5 different dose strengths, which are injected under the skin. The starting dose is 0.25 mg once a week, and you will gradually increase your dose every four weeks. Your health care provider can select either 1.7 mg or 2.4 mg for your maintenance dose.

Wegovy (semaglutide) injection 2.4 mg is indicated for chronic weight management for adults with obesity and to reduce the risk of major adverse cardiovascular events in adults with obesity or overweight and cardiovascular disease. Read Important Safety and Prescribing Info, including Boxed Warning.

Wegovy ® can be administered any time of day. Wegovy ® should be injected subcutaneously in the abdomen, thigh, or upper arm. Patients can rotate the injection site each time. The injection will take ~10 seconds, during which patients will hear 2 clicks.

Nov 19, 2024 · Wegovy (semaglutide) is a glucagon -like peptide -1 (GLP-1) receptor agonist indicated as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one w...

Aug 15, 2024 · Wegovy is a once-weekly injectable drug used to help regulate blood sugar levels and help with weight loss. Wegovy is administered weekly through an auto-injector pen. Recommended injection sites include the abdomen, front of the thighs, and upper arms.

Wegovy ® (semaglutide) injection 2.4 mg is indicated in combination with a reduced calorie diet and increased physical activity: to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with established cardiovascular disease and either obesity or overweight